1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents. 2020; 55(3):105924. PMID:
32081636.
Article
2. Wang C, Horby PW, Hayden FG, Gao GF. A novel coronavirus outbreak of global health concern. Lancet. 2020; 395(10223):470–473. PMID:
31986257.
Article
3. Witze A. Universities will never be the same after the coronavirus crisis. Nature. 2020; 582(7811):162–164. PMID:
32504014.
Article
4. Weiner DL, Balasubramaniam V, Shah SI, Javier JR. Pediatric Policy Council. COVID-19 impact on research, lessons learned from COVID-19 research, implications for pediatric research. Pediatr Res. 2020; 88(2):148–150. PMID:
32544922.
Article
6. Ahmed S, Zimba O, Gasparyan AY. Moving towards online rheumatology education in the era of COVID-19. Clin Rheumatol. 2020; 39(11):3215–3222. PMID:
32939569.
Article
7. Saberi P. Research in the time of coronavirus: continuing ongoing studies in the midst of the COVID-19 pandemic. AIDS Behav. 2020; 24(8):2232–2235. PMID:
32303924.
Article
10. Barroga E. Enhancing clear expression of research questions, hypotheses, and objectives through effective use of scientific English. Cent Asian J Med Hypotheses Ethics. 2020; 1(1):63–65.
Article
11. Yakhontova T. Conventions of English research discourse and the writing of non-Anglophone authors. J Korean Med Sci. 2020; 35(40):e331. PMID:
33075853.
Article
13. Shehata MH, Abouzeid E, Wasfy NF, Abdelaziz A, Wells RL, Ahmed SA. Medical education adaptations post COVID-19: an Egyptian reflection. J Med Educ Curric Dev. 2020; 7:1–9.
Article
14. Archibald MM, Ambagtsheer RC, Casey MG, Lawless M. Using Zoom videoconferencing for qualitative data collection: perceptions and experiences of researchers and participants. Int J Qual Methods. 2019; 18:1–8.
Article
16. Zimba O, Radchenko O, Strilchuk L. Social media for research, education and practice in rheumatology. Rheumatol Int. 2020; 40(2):183–190. PMID:
31863133.
Article
17. Omary MB, Eswaraka J, Kimball SD, Moghe PV, Panettieri RA Jr, Scotto KW. The COVID-19 pandemic and research shutdown: staying safe and productive. J Clin Invest. 2020; 130(6):2745–2748. PMID:
32243259.
Article
19. Pfefferbaum B, North CS. Mental health and the COVID-19 pandemic. N Engl J Med. 2020; 383(6):510–512. PMID:
32283003.
Article
22. Gupta L, Gasparyan AY, Misra DP, Agarwal V, Zimba O, Yessirkepov M. Information and misinformation on COVID-19: a cross-sectional survey study. J Korean Med Sci. 2020; 35(27):e256. PMID:
32657090.
Article
23. Arts D, McGill L. Leveraging standardised data in response to the novel coronavirus outbreak. Med Writ. 2020; 29(2):32–35.
24. London AJ, Kimmelman J. Against pandemic research exceptionalism. Science. 2020; 368(6490):476–477. PMID:
32327600.
Article
25. Piller C, Servick K. Two elite medical journals retract coronavirus papers over data integrity questions. Science. Forthcoming. 2020; DOI:
10.1126/science.abd1697.
Article
27. Gianola S, Jesus TS, Bargeri S, Castellini G. Characteristics of academic publications, preprints, and registered clinical trials on the COVID-19 pandemic. PLoS One. 2020; 15(10):e0240123. PMID:
33022014.
Article
28. Wehner MR, Li Y, Nead KT. Comparison of the proportions of female and male corresponding authors in preprint research repositories before and during the COVID-19 pandemic. JAMA Netw Open. 2020; 3(9):e2020335. PMID:
32940678.
Article
29. Servick K. COVID-19 data scandal prompts tweaks to elite journal's review process. Science. 2020.
Article
31. Barroga E. Innovative strategies for peer review. J Korean Med Sci. 2020; 35(20):e138. PMID:
32449322.
Article
32. Gertel A. Rush to publication – What do we have to lose? Med Writ. 2020; 29(2):14–15.
33. Gupta L, Gasparyan AY, Zimba O, Misra DP. Scholarly publishing and journal targeting in the time of the Coronavirus Disease 2019 (COVID-19) pandemic: a cross-sectional survey of rheumatologists and other specialists. Rheumatol Int. 2020; 40(12):2023–2030. PMID:
33048199.
Article